FRAMINGHAM (01/15/2004) - Andre G. Pernet takes over as president at Quark Biotech Inc., a privately held company pioneering endpoint-driven drug development (ED3), described as a vertically integrated development approach. Pernet is currently the chairman of CURx Pharma Inc.
- Free Whitepaper! The 5 criteria to help you select the right analytics platform for your organization.
- Free Whitepaper! Learn how IT is evolving from producer to enabler, and fostering collaboration around analytics.
- Free Whitepaper! Learn how to create an analytics environment that is governed, scalable and self-serve.